rs12085877
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000400897.8(MASP2):c.1316G>A(p.Arg439His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00517 in 1,610,136 control chromosomes in the GnomAD database, including 375 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R439C) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000400897.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MASP2 | NM_006610.4 | c.1316G>A | p.Arg439His | missense_variant | 11/11 | ENST00000400897.8 | NP_006601.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MASP2 | ENST00000400897.8 | c.1316G>A | p.Arg439His | missense_variant | 11/11 | 1 | NM_006610.4 | ENSP00000383690 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0271 AC: 4126AN: 152130Hom.: 187 Cov.: 33
GnomAD3 exomes AF: 0.00714 AC: 1745AN: 244258Hom.: 74 AF XY: 0.00515 AC XY: 683AN XY: 132568
GnomAD4 exome AF: 0.00288 AC: 4195AN: 1457888Hom.: 188 Cov.: 34 AF XY: 0.00241 AC XY: 1748AN XY: 724914
GnomAD4 genome AF: 0.0271 AC: 4127AN: 152248Hom.: 187 Cov.: 33 AF XY: 0.0260 AC XY: 1932AN XY: 74426
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 26, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Immunodeficiency due to MASP-2 deficiency Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at